For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230526:nRSZ8608Aa&default-theme=true
RNS Number : 8608A Solgenics Limited 26 May 2023
News Release
Result of GM
26 May 2023: Solgenics Limited ("Solgenics" or the "Company") (AIM: SGN)
announces that, at the General Meeting ("GM") of the Company held today, the
special resolutions to approve the cancellation of shares from AIM and to
amend the Articles of Association were duly passed on a poll. The Company
received authorised votes from 317,857,465 shares, representing 56% of the
Company's shares in issue. Votes in support of both resolutions were 98% and
97% respectively.
The last day of dealings in the Company's Ordinary Shares on AIM will be
Tuesday 6 June 2023 and the Cancellation will become effective at 7.00 a.m. on
Wednesday 7 June 2023, subject to a dealing notice, as defined in the AIM
Rules for Companies, being issued.
Enquiries
For further information please visit www.solgenics.com
(http://www.solgenics.com) or contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566
Liberum Capital Limited: Scott Mathieson, Edward Thomas, Kane Collings +44 (0) 20 3100 2000
NOMAD & Joint Broker
Novum Securities Limited Colin Rowbury +44 (0) 20 7399 9427
Joint Broker
Elizabeth Johnson +44 (0) 777 56 55 927
Pimlico Advisory Ltd
Investor Relations
About Solgenics
Solgenics is an African renewable energy development company focused on the
development of a 300MW solar PV plus BESS power project in the Tete Province
in northern Mozambique (the "Tete Solar Project").
It is the intention that the Tete Solar Project will connect to the Mozambique
grid with target power offtakers in Mozambique and the Southern African Power
Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's leading
sustainable energy resources and is fully aligned with Government's objective
to become a champion for energy transition impacting all Southern Africa.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ROMFLFLSEDIRFIV